Aarhus University Seal

STEFFEN THIEL: Innate Immune system

Steffen Thiel’s research focus is the processes that create inflammation in the body and his group is among the leaders in the field of immune recognition.

Steffen Thiel has been deeply involved in the description of the proteins and processes in the part of the immune system referred to as the complement system.

Recent publications

Sort by: Date | Author | Title

Hansen, T. K., Gall, M.-A., Tarnow, L., Thiel, S., Parving, H.-H. & Flyvbjerg, A. (2009). Mannanbindende lektin og mortalitet hos patienter med type 2-diabetes - sekundærpublikation. Ugeskrift for Læger, 171(6), 426-429.
Garred, P., Thiel, S., Madsen, H., Ryder, L. P., Jensenius, J. C. & Svejgaard, A. (1993). Mangel på mannan-bindende protein--et nyopdaget komplementdefektsyndrom. Ugeskrift for Læger, 155(1), 25-9.
Egli, A., Schäfer, J., Osthoff, M., Thiel, S., Mikkelsen, C., Rauch, A., Hirsch, H. H., Bucher, H. C., Young, J., Jensenius, J. C., Battegay, M., Trendelenburg, M. & Swiss HIV Cohort Study (2013). Low Levels of Mannan-Binding Lectin or Ficolins Are Not Associated with an Increased Risk of Cytomegalovirus Disease in HIV-Infected Patients. PLoS One, 8(1), e51983. https://doi.org/10.1371/journal.pone.0051983
Smedbråten, J., Mjøen, G., Hartmann, A., Åsberg, A., Rollag, H., Mollnes, T. E., Sandvik, L., Fagerland, M. W., Thiel, S. & Sagedal, S. (2016). Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipients. BMC Nephrology, 17(1), 148. Article 148. https://doi.org/10.1186/s12882-016-0373-9